Cytokinetics, Incorporated
CYTK
$64.66
$1.151.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 962.54M | 858.14M | 938.22M | 1.08B | 1.01B |
| Total Receivables | 1.81M | 8.41M | 2.01M | 16.65M | 244.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.01M | 20.00M | 15.82M | 15.28M | 6.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 977.35M | 886.54M | 956.05M | 1.11B | 1.02B |
|
|
|||||
| Total Current Assets | 977.35M | 886.54M | 956.05M | 1.11B | 1.02B |
| Net Property, Plant & Equipment | 153.58M | 146.34M | 144.61M | 140.97M | 140.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.81M | 14.55M | 12.70M | 7.71M | 7.73M |
| Total Assets | 1.44B | 1.23B | 1.26B | 1.40B | 1.44B |
|
|
|||||
| Total Accounts Payable | 22.08M | 16.23M | 13.94M | 20.37M | 11.58M |
| Total Accrued Expenses | 61.63M | 52.32M | 43.36M | 55.32M | 49.83M |
| Short-term Debt | 16.90M | -- | -- | 11.30M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.93M | 33.99M | 32.53M | 30.70M | 30.38M |
| Total Finance Division Other Current Liabilities | 3.60M | 28.54M | 69.89M | 61.98M | 18.03M |
| Total Other Current Liabilities | 3.60M | 28.54M | 69.89M | 61.98M | 18.03M |
| Total Current Liabilities | 142.14M | 131.06M | 159.73M | 179.67M | 109.81M |
|
|
|||||
| Total Current Liabilities | 142.14M | 131.06M | 159.73M | 179.67M | 109.81M |
| Long-Term Debt | 1.18B | 846.75M | 764.57M | 768.60M | 763.10M |
| Short-term Debt | 16.90M | -- | -- | 11.30M | -- |
| Capital Leases | 110.66M | 111.03M | 113.35M | 112.58M | 114.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 520.11M | 505.52M | 492.82M | 476.19M | 462.31M |
| Total Liabilities | 1.96B | 1.59B | 1.53B | 1.54B | 1.45B |
|
|
|||||
| Common Stock & APIC | 2.78B | 2.63B | 2.60B | 2.56B | 2.53B |
| Retained Earnings | -3.30B | -3.00B | -2.86B | -2.70B | -2.55B |
| Treasury Stock & Other | 34.00K | -158.00K | 1.55M | 2.40M | 5.39M |
| Total Common Equity | -521.12M | -368.72M | -266.41M | -135.37M | -13.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -521.12M | -368.72M | -266.41M | -135.37M | -13.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -521.12M | -368.72M | -266.41M | -135.37M | -13.91M |
|
|
|||||